Search Results 211-220 of 13739 for monoclonal antibody

  1. A Study Of Belantamab Mafodotin (GSK2857916) In Multiple Myeloma Participants With Normal And Impaired Renal Function - Mayo Clinic

    Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate (ADC) containing humanized anti- B-cell maturation antigen (BCMA) monoclonal antibody (mAb).

  2. A Study Evaluating Pembrolizumab And Epacadostat In Treating Participants With Recurrent, Persistent, Or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of ... History of severe hypersensitivity reaction to any monoclonal antibody.

  3. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  4. Hematology - Clinical trials

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. ... * Whether the body makes antibodies ...

  5. Cancer to COVID-19: Experimental treatment pivots in record time - Mayo Clinic News Network

    But then the pandemic started. Literature Lightbulb. Lenzilumab is a monoclonal antibody drug. Read more about monoclonal antibodies in, "Monoclonal Antibodies: ...

  6. Monoclonal gammopathy of undetermined significance (MGUS) - Diagnosis and treatment - Mayo Clinic

    It also helps tell the difference between a monoclonal protein and a polyclonal pattern. A polyclonal pattern means several types of antibodies are increased.

  7. Hematology - Clinical trials

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  8. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. ... * Whether the body makes antibodies ...

  9. Small Lymphocytic Lymphoma Clinical Trials - Mayo Clinic Research

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread ...

  10. Colon Melanoma Clinical Trials

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...